Josefin Ahnstrom

Du Cane Road
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

TFPIα inhibition by Andexanet alfa is partially restored by protein S and factor V-short.

TFPIα inhibition by Andexanet alfa is partially restored by protein S and factor V-short.

Journal: Blood advances

Published: February 19, 2026

TFPIα inhibition by andexanet alfa is partially restored by protein S and factor V-short.

TFPIα inhibition by andexanet alfa is partially restored by protein S and factor V-short.

Journal: Blood advances

Published: February 19, 2026

Mechanisms of thrombin inhibition by protein S and the TFPIα-fVshort-protein S complex.

Mechanisms of thrombin inhibition by protein S and the TFPIα-fVshort-protein S complex.

Journal: ArXiv

Published: December 19, 2025

Mechanisms of thrombin inhibition by protein S and the TFPIα-fVshort-protein S complex.

Mechanisms of thrombin inhibition by protein S and the TFPIα-fVshort-protein S complex.

Journal: Biophysical journal

Published: December 11, 2025

Association of coagulation dysfunction with thrombosis, bleeding, and mortality in patients supported by veno-venous extracorporeal membrane oxygenation for viral pneumonia.

Association of coagulation dysfunction with thrombosis, bleeding, and mortality in patients supported by veno-venous extracorporeal membrane oxygenation for viral pneumonia.

Journal: Journal of thrombosis and haemostasis : JTH

Published: April 14, 2025

Pro-Coagulant Lipids in Physiological Ratios Found in the Activated Platelet Membrane Do Not Impact Clot Structure or Fibrinolysis in Purified Assays.

Pro-Coagulant Lipids in Physiological Ratios Found in the Activated Platelet Membrane Do Not Impact Clot Structure or Fibrinolysis in Purified Assays.

Journal: Journal of blood medicine

Published: March 12, 2025

Role of von Willebrand factor (VWF), platelets, and aberrant flow in the initiation of venous thrombosis.

Role of von Willebrand factor (VWF), platelets, and aberrant flow in the initiation of venous thrombosis.

Journal: Science advances

Published: February 05, 2025

Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S.

Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 29, 2024

Cleavage of Cartilage Oligomeric Matrix Protein (COMP) by ADAMTS4 generates a neoepitope associated with osteoarthritis and other forms of degenerative joint disease.

Cleavage of Cartilage Oligomeric Matrix Protein (COMP) by ADAMTS4 generates a neoepitope associated with osteoarthritis and other forms of degenerative joint disease.

Journal: Matrix biology : journal of the International Society for Matrix Biology

Published: October 29, 2024

A cell-based model to study mechanisms of endothelial-dependent thrombin generation in response to inflammation and its modulation by hydroxychloroquine.

A cell-based model to study mechanisms of endothelial-dependent thrombin generation in response to inflammation and its modulation by hydroxychloroquine.

Journal: Research and practice in thrombosis and haemostasis

Published: October 29, 2024

Tissue factor pathway inhibitor - cofactor-dependent regulation of the initiation of coagulation.

Tissue factor pathway inhibitor - cofactor-dependent regulation of the initiation of coagulation.

Journal: Current opinion in hematology

Published: September 11, 2024

The common VTE-protective G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding.

The common VTE-protective G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding.

Journal: Blood advances

Published: July 10, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026